Anti-vascular endothelial growth factor (VEGF) has emerged as a therapeutic target in several malignancies, including cervical cancer where it’s considered a growth factor responsible for the proliferation, migration and survival of endothelial cells [41]. This evidence concerns the gene VEGFA and cervical carcinoma.